News & AnalysisBiotech startup Laronde nets $440m Series B roundBiotech startup Laronde has raised $440 million in Series B financing.ByIris Dorbian30 August 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsCanadaNorth AmericaUSHealthcareBriefs